• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于脑癌治疗的聚合物纳米颗粒:当前方法综述

Polymeric Nanoparticles in Brain Cancer Therapy: A Review of Current Approaches.

作者信息

Caraway Chad A, Gaitsch Hallie, Wicks Elizabeth E, Kalluri Anita, Kunadi Navya, Tyler Betty M

机构信息

Hunterian Neurosurgical Research Laboratory, Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.

NIH-Oxford-Cambridge Scholars Program, Wellcome-MRC Cambridge Stem Cell Institute and Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 1TN, UK.

出版信息

Polymers (Basel). 2022 Jul 21;14(14):2963. doi: 10.3390/polym14142963.

DOI:10.3390/polym14142963
PMID:35890738
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9322801/
Abstract

Translation of novel therapies for brain cancer into clinical practice is of the utmost importance as primary brain tumors are responsible for more than 200,000 deaths worldwide each year. While many research efforts have been aimed at improving survival rates over the years, prognosis for patients with glioblastoma and other primary brain tumors remains poor. Safely delivering chemotherapeutic drugs and other anti-cancer compounds across the blood-brain barrier and directly to tumor cells is perhaps the greatest challenge in treating brain cancer. Polymeric nanoparticles (NPs) are powerful, highly tunable carrier systems that may be able to overcome those obstacles. Several studies have shown appropriately-constructed polymeric NPs cross the blood-brain barrier, increase drug bioavailability, reduce systemic toxicity, and selectively target central nervous system cancer cells. While no studies relating to their use in treating brain cancer are in clinical trials, there is mounting preclinical evidence that polymeric NPs could be beneficial for brain tumor therapy. This review includes a variety of polymeric NPs and how their associated composition, surface modifications, and method of delivery impact their capacity to improve brain tumor therapy.

摘要

将新型脑癌治疗方法转化为临床应用至关重要,因为原发性脑肿瘤每年在全球导致超过20万例死亡。多年来,许多研究致力于提高生存率,但胶质母细胞瘤和其他原发性脑肿瘤患者的预后仍然很差。安全地将化疗药物和其他抗癌化合物穿过血脑屏障并直接递送至肿瘤细胞,可能是治疗脑癌面临的最大挑战。聚合物纳米颗粒(NPs)是强大的、高度可调节的载体系统,或许能够克服这些障碍。多项研究表明,构建合适的聚合物纳米颗粒可穿过血脑屏障,提高药物生物利用度,降低全身毒性,并选择性地靶向中枢神经系统癌细胞。虽然尚无关于其用于治疗脑癌的研究进入临床试验阶段,但越来越多的临床前证据表明,聚合物纳米颗粒可能有益于脑肿瘤治疗。本综述涵盖了多种聚合物纳米颗粒,以及它们的相关组成、表面修饰和递送方法如何影响其改善脑肿瘤治疗的能力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8144/9322801/0881698dd72f/polymers-14-02963-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8144/9322801/ffc2507a29c0/polymers-14-02963-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8144/9322801/40e59be7a7c2/polymers-14-02963-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8144/9322801/0881698dd72f/polymers-14-02963-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8144/9322801/ffc2507a29c0/polymers-14-02963-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8144/9322801/40e59be7a7c2/polymers-14-02963-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8144/9322801/0881698dd72f/polymers-14-02963-g003.jpg

相似文献

1
Polymeric Nanoparticles in Brain Cancer Therapy: A Review of Current Approaches.用于脑癌治疗的聚合物纳米颗粒:当前方法综述
Polymers (Basel). 2022 Jul 21;14(14):2963. doi: 10.3390/polym14142963.
2
Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art.用于治疗多形性胶质母细胞瘤的纳米载体:最新进展。
J Control Release. 2016 Apr 10;227:23-37. doi: 10.1016/j.jconrel.2016.02.026. Epub 2016 Feb 16.
3
Polymeric nanoparticles for drug delivery in glioblastoma: State of the art and future perspectives.用于胶质母细胞瘤药物递送的聚合物纳米粒:现状和未来展望。
J Control Release. 2022 Sep;349:649-661. doi: 10.1016/j.jconrel.2022.07.023. Epub 2022 Jul 28.
4
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.癌症的先进靶向疗法:药物纳米载体,化疗的未来。
Eur J Pharm Biopharm. 2015 Jun;93:52-79. doi: 10.1016/j.ejpb.2015.03.018. Epub 2015 Mar 23.
5
Current Nanoparticle Approaches in Nose to Brain Drug Delivery and Anticancer Therapy - A Review.当前用于经鼻脑递药和抗癌治疗的纳米颗粒方法 - 综述。
Curr Pharm Des. 2020;26(11):1128-1137. doi: 10.2174/1381612826666200116153912.
6
Nanobiotechnology-based drug delivery in brain targeting.基于纳米生物技术的脑靶向给药
Curr Pharm Biotechnol. 2013;14(15):1264-74. doi: 10.2174/1389201015666140608143719.
7
Targeting Non-coding RNA for Glioblastoma Therapy: The Challenge of Overcomes the Blood-Brain Barrier.靶向非编码RNA治疗胶质母细胞瘤:克服血脑屏障的挑战
Front Med Technol. 2021 Aug 10;3:678593. doi: 10.3389/fmedt.2021.678593. eCollection 2021.
8
Macromolecular Drug Carriers for Targeted Glioblastoma Therapy: Preclinical Studies, Challenges, and Future Perspectives.用于靶向胶质母细胞瘤治疗的大分子药物载体:临床前研究、挑战与未来展望
Front Oncol. 2018 Dec 17;8:624. doi: 10.3389/fonc.2018.00624. eCollection 2018.
9
Nanoparticles targeting Sialyl-Tn for efficient tyrosine kinase inhibitor delivery in gastric cancer.靶向 Sialyl-Tn 的纳米颗粒用于胃癌中酪氨酸激酶抑制剂的有效递送。
Acta Biomater. 2023 Oct 15;170:142-154. doi: 10.1016/j.actbio.2023.08.014. Epub 2023 Aug 14.
10
Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier.聚合物纳米粒用于血脑屏障药物递送的潜力。
Curr Med Chem. 2013;20(17):2212-25. doi: 10.2174/0929867311320170006.

引用本文的文献

1
Nanoparticles for Cancer Immunotherapy: Innovations and Challenges.用于癌症免疫治疗的纳米颗粒:创新与挑战
Pharmaceuticals (Basel). 2025 Jul 22;18(8):1086. doi: 10.3390/ph18081086.
2
Nanoparticle-Based Delivery Strategies for Combating Drug Resistance in Cancer Therapeutics.基于纳米颗粒的癌症治疗中抗耐药性递送策略
Cancers (Basel). 2025 Aug 11;17(16):2628. doi: 10.3390/cancers17162628.
3
Nanoparticle‑based delivery systems for targeted therapy in brain tumors: Progress, challenges and perspectives (Review).基于纳米颗粒的脑肿瘤靶向治疗递送系统:进展、挑战与展望(综述)

本文引用的文献

1
Transferrin Receptor-Targeted Nanocarriers: Overcoming Barriers to Treat Glioblastoma.转铁蛋白受体靶向纳米载体:克服胶质母细胞瘤治疗障碍
Pharmaceutics. 2022 Jan 25;14(2):279. doi: 10.3390/pharmaceutics14020279.
2
Long-term effectiveness of Gliadel implant for malignant glioma and prognostic factors for survival: 3-year results of a postmarketing surveillance in Japan.Gliadel植入物治疗恶性胶质瘤的长期疗效及生存预后因素:日本上市后监测的3年结果
Neurooncol Adv. 2022 Jan 12;4(1):vdab189. doi: 10.1093/noajnl/vdab189. eCollection 2022 Jan-Dec.
3
Biocompatible and Biodegradable Polymer Optical Fiber for Biomedical Application: A Review.
Int J Oncol. 2025 Oct;67(4). doi: 10.3892/ijo.2025.5789. Epub 2025 Aug 24.
4
Antibody-conjugated polymer nanoparticles for brain cancer.用于脑癌的抗体偶联聚合物纳米颗粒。
Drug Deliv Transl Res. 2025 Aug 20. doi: 10.1007/s13346-025-01947-0.
5
Overcoming the blood-brain barrier (BBB) in pediatric CNS tumors: immunotherapy and nanomedicine-driven strategies.克服小儿中枢神经系统肿瘤中的血脑屏障:免疫疗法和纳米医学驱动策略
Med Oncol. 2025 Aug 19;42(10):431. doi: 10.1007/s12032-025-02984-y.
6
Polymeric Nanoparticle-Mediated Photodynamic Therapy: A Synergistic Approach for Glioblastoma Treatment.聚合物纳米颗粒介导的光动力疗法:一种用于胶质母细胞瘤治疗的协同方法。
Pharmaceuticals (Basel). 2025 Jul 18;18(7):1057. doi: 10.3390/ph18071057.
7
Superparamagnetic iron oxide nanoparticles (SPIONs) in targeting brain tumors: advances and challenges.靶向脑肿瘤的超顺磁性氧化铁纳米颗粒(SPIONs):进展与挑战
Med Oncol. 2025 Jul 16;42(8):338. doi: 10.1007/s12032-025-02913-z.
8
Pharmaceutical 3D Printing Technology Integrating Nanomaterials and Nanodevices for Precision Neurological Therapies.集成纳米材料和纳米器件用于精准神经治疗的药物3D打印技术
Pharmaceutics. 2025 Mar 9;17(3):352. doi: 10.3390/pharmaceutics17030352.
9
Advancements in long non-coding RNA-based therapies for cancer: targeting, delivery, and clinical implications.基于长非编码 RNA 的癌症治疗的进展:靶向、递送和临床意义。
Med Oncol. 2024 Oct 20;41(11):292. doi: 10.1007/s12032-024-02534-y.
10
Anticancer therapeutic potential of multimodal targeting agent- "phosphorylated galactosylated chitosan coated magnetic nanoparticles" against N-nitrosodiethylamine-induced hepatocellular carcinoma.多模态靶向剂“磷酸化半乳糖基化壳聚糖包被磁性纳米颗粒”对N-亚硝基二乙胺诱导的肝细胞癌的抗癌治疗潜力
Drug Deliv Transl Res. 2025 Mar;15(3):1023-1042. doi: 10.1007/s13346-024-01655-1. Epub 2024 Jul 11.
用于生物医学应用的生物相容和可生物降解的聚合物光纤:综述。
Biosensors (Basel). 2021 Nov 23;11(12):472. doi: 10.3390/bios11120472.
4
Nanotherapeutics Overcoming the Blood-Brain Barrier for Glioblastoma Treatment.用于胶质母细胞瘤治疗的克服血脑屏障的纳米疗法。
Front Pharmacol. 2021 Nov 25;12:786700. doi: 10.3389/fphar.2021.786700. eCollection 2021.
5
mPEG-PLGA Nanoparticles Labelled with Loaded or Conjugated Rhodamine-B for Potential Nose-to-Brain Delivery.负载或偶联若丹明B的甲氧基聚乙二醇-聚乳酸-羟基乙酸共聚物纳米颗粒用于潜在的鼻脑递送
Pharmaceutics. 2021 Sep 18;13(9):1508. doi: 10.3390/pharmaceutics13091508.
6
Investigating receptor-mediated antibody transcytosis using blood-brain barrier organoid arrays.利用血脑屏障类器官芯片研究受体介导的抗体穿胞转运。
Fluids Barriers CNS. 2021 Sep 20;18(1):43. doi: 10.1186/s12987-021-00276-x.
7
EGFRvIII peptide nanocapsules and bevacizumab nanocapsules: a nose-to-brain multitarget approach against glioblastoma.表皮生长因子受体III型变异体(EGFRvIII)肽纳米胶囊和贝伐单抗纳米胶囊:一种针对胶质母细胞瘤的鼻脑多靶点治疗方法
Nanomedicine (Lond). 2021 Aug;16(20):1775-1790. doi: 10.2217/nnm-2021-0169. Epub 2021 Jul 27.
8
Functionalized polyanhydride nanoparticles for improved treatment of mitochondrial dysfunction.用于改善线粒体功能障碍治疗的功能化聚酸酐纳米颗粒。
J Biomed Mater Res B Appl Biomater. 2022 Feb;110(2):450-459. doi: 10.1002/jbm.b.34922. Epub 2021 Jul 27.
9
Development of Polymeric Nanoparticles for Blood-Brain Barrier Transfer-Strategies and Challenges.用于血脑屏障传递的聚合物纳米粒子的开发——策略和挑战。
Adv Sci (Weinh). 2021 Mar 7;8(10):2003937. doi: 10.1002/advs.202003937. eCollection 2021 May.
10
A novel biodegradable injectable chitosan hydrogel for overcoming postoperative trauma and combating multiple tumors.一种新型可生物降解的壳聚糖水凝胶,用于克服术后创伤和对抗多种肿瘤。
Carbohydr Polym. 2021 Aug 1;265:118065. doi: 10.1016/j.carbpol.2021.118065. Epub 2021 Apr 16.